A new two-step algorithm for the treatment of COPD.
Dept of Pneumology, Hospital Universitari Vall d'Hebron, Centro de Investigación Biomédica en Red Enfermedades Respiratorias (CIBERES), Barcelona, Spain mmiravitlles@vhebron.net.
Marc
M
Miravitlles
Division of Pulmonary Diseases and Critical Care Medicine, School of Medicine, The University of Texas Health Science Center, San Antonio, TX, USA.|Audie L. Murphy Memorial VA Hospital, South Texas Veterans Health Care System, San Antonio, TX, USA.
Antonio
A
Anzueto
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000465:Algorithms; D000631:Aminopyridines / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001549:Benzamides / Q000008:administration & dosage; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D003521:Cyclopropanes / Q000008:administration & dosage; D006801:Humans; D018942:Macrolides / Q000737:chemistry; D018727:Muscarinic Antagonists / Q000008:administration & dosage*; D010641:Phenotype; D029424:Pulmonary Disease, Chronic Obstructive / Q000503:physiopathology / Q000628:therapy*; D015272:Pulmonary Medicine / Q000592:standards*
D000305:Adrenal Cortex Hormones; D000631:Aminopyridines; D000893:Anti-Inflammatory Agents; D001549:Benzamides; D001993:Bronchodilator Agents; D003521:Cyclopropanes; D018942:Macrolides; D018727:Muscarinic Antagonists; C424423:Roflumilast